-
EP2368877
European procedure
Extract from the Register of European Patents
EP Citations: EP2368877
| Cited in | Search | Type: | Patent literature | Publication No.: | JPH09124691
[I] (GREEN CROSS CORP et al.) | Type: | Patent literature | Publication No.: | US5371072
[I] (WEBB THOMAS R et al.) | Type: | Patent literature | Publication No.: | US4880780
[I] (TRAINOR DIANE A et al.) | Type: | Patent literature | Publication No.: | US5656600
[I] (ABELMAN MATTHEW M et al.) | Type: | Patent literature | Publication No.: | WO0009543
[I] (BOEHRINGER INGELHEIM CA LTD et al.) | Type: | Patent literature | Publication No.: | WO9907733
[I] (BOEHRINGER INGELHEIM CA LTD et al.) | Type: | Patent literature | Publication No.: | WO0009558
[I] (BOEHRINGER INGELHEIM CA LTD et al.) | Type: | Patent literature | Publication No.: | WO9817679
[I] (VERTEX PHARMA et al.) | Type: | Patent literature | Publication No.: | WO9907734
[I] (BOEHRINGER INGELHEIM CA LTD et al.) | Cited in | by applicant | Type: | Patent literature | Publication No.: | WO0009558
| Type: | Patent literature | Publication No.: | WO0009543
| Type: | Patent literature | Publication No.: | WO9964442
| Type: | Patent literature | Publication No.: | WO9907733
| Type: | Patent literature | Publication No.: | WO9907734
| Type: | Patent literature | Publication No.: | WO9950230
| Type: | Patent literature | Publication No.: | WO9846630
| Type: | Patent literature | Publication No.: | WO9817679
| Type: | Patent literature | Publication No.: | WO9743310
| Type: | Patent literature | Publication No.: | US5990276
| Type: | Patent literature | Publication No.: | US3840556
| Type: | Patent literature | Publication No.: | US3719667
| Type: | Non-patent literature | Publication information: | A. ALBERTI ET AL.: "Natural History of Hepatitis C", J. HEPATOLOGY, vol. 31, no. 1, 1999, pages 17 - 24 | Type: | Non-patent literature | Publication information: | M.J. ALTER: "Hepatitis C Virus Infection in the United States", J. HEPATOLOSV., vol. 31, no. 1, 1999, pages 88 - 91 | Type: | Non-patent literature | Publication information: | D. LAVANCHY: "Global Surveillance and Control of Hepatitis C", J. VIRAL HEPATITIS, vol. 6, 1999, pages 35 - 47 | Type: | Non-patent literature | Publication information: | Q.-L. CHOO ET AL.: "Genetic Organization and Diversity of the Hepatitis C Virus", PROC. NATL. ACAD. SCI. USA, vol. 88, 1991, pages 2451 - 2455 | Type: | Non-patent literature | Publication information: | N. KATO ET AL.: "Molecular Cloning of the Human Hepatitis C Virus Genome From Japanese Patients with Non-A, Non-B Hepatitis", PROC. NATL. ACAD. SCI. USA, vol. 87, 1990, pages 9524 - 9528 | Type: | Non-patent literature | Publication information: | A. TAKAMIZAWA ET AL.: "Structure and Organization of the Hepatitis C Virus Genome Isolated From Human Carriers", J. VIROL., vol. 65, 1991, pages 1105 - 1113 | Type: | Non-patent literature | Publication information: | R. BARTENSCHLAGER ET AL.: "Nonstructural Protein 3 of the Hepatitis C Virus Encodes a Serine-Type Proteinase Required for Cleavage at the NS3/4 and NS4/5 Junctions", J. VIROL., vol. 67, 1993, pages 3835 - 3844 | Type: | Non-patent literature | Publication information: | A. GRAKOUI ET AL.: "Characterization of the Hepatitis C Virus-Encoded Serine Proteinase: Determination of Proteinase-Dependent Polyprotein Cleavage Sites", J. VIROL., vol. 67, 1993, pages 2832 - 2843 | Type: | Non-patent literature | Publication information: | A. GRAKOUI ET AL.: "Expression and Identification of Hepatitis C Virus Polyprotein Cleavage Products", J. VIROL., vol. 67, 1993, pages 1385 - 1395 | Type: | Non-patent literature | Publication information: | L. TOMEI ET AL.: "NS3 is a serine protease required for processing of hepatitis C virus polyprotein", J. VIROL., vol. 67, 1993, pages 4017 - 4026 | Type: | Non-patent literature | Publication information: | C. LIN ET AL.: "Hepatitis C Virus NS3 Serine Proteinase: Trans-Cleavage Requirements and Processing Kinetics", J. VIROL., vol. 68, 1994, pages 8147 - 8157 | Type: | Non-patent literature | Publication information: | T.J. CHAMBERS ET AL.: "Evidence that the N-terminal Domain of Nonstructural Protein NS3 From Yellow Fever Virus is a Serine Protease Responsible for Site-Specific Cleavages in the Viral Polyprotein", PROC. NATL. ACAD. SCI. USA, vol. 87, 1990, pages 8898 - 8902 | Type: | Non-patent literature | Publication information: | C.M. RICE ET AL.: "Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3'-nontranslated region are essential for virus replication in vivo.", J. VIROL., vol. 74, no. 4, 2000, pages 2046 - 51 | Type: | Non-patent literature | Publication information: | M. LLINS-BRUNET ET AL., BIOORG. MED. CHEM. LETT., vol. 8, 1998, pages 1713 - 1718 | Type: | Non-patent literature | Publication information: | W. HAN ET AL., BIOORG. MED. CHEM. LETT., vol. 10, 2000, pages 711 - 713 | Type: | Non-patent literature | Publication information: | R. DUNSDON ET AL., BIOORG. MED. CHEM. LETT., vol. 10, 2000, pages 1571 - 1579 | Type: | Non-patent literature | Publication information: | M. LLINAS-BRUNET ET AL., BIOORG. MED. CHEM. LETT., vol. 10, 2000, pages 2267 - 2270 | Type: | Non-patent literature | Publication information: | S. LAPLANTE ET AL., BIOORG. MED. CHEM. LETT., vol. 10, 2000, pages 2271 - 2274 | Type: | Non-patent literature | Publication information: | M.A. WALKER: "Hepatitis C Virus: an Overview of Current Approaches and Progress", DDT, vol. 4, 1999, pages 518 - 529 | Type: | Non-patent literature | Publication information: | D. MORADPOUR ET AL.: "Current and Evolving Therapies for Hepatitis C", EUR. J. GASTROENTEROL. HEPATOL., vol. 11, 1999, pages 1199 - 1202 | Type: | Non-patent literature | Publication information: | H.L.A. JANSSEN ET AL.: "Suicide Associated with Alfa-Interferon Therapy for Chronic Viral Hepatitis", J. HEPATOL., vol. 21, 1994, pages 241 - 243 | Type: | Non-patent literature | Publication information: | P.F. RENAULT ET AL.: "Side effects of alpha interferon", SEMINARS IN LIVER DISEASE, vol. 9, 1989, pages 273 - 277 | Type: | Non-patent literature | Publication information: | 0. WEILAND: "Interferon Therapy in Chronic Hepatitis C Virus Infection", FEMS MICROBIOL. REV., vol. 14, 1994, pages 279 - 288 | Type: | Non-patent literature | Publication information: | GRECO; PARK; RUSTOM: "Application of a New Approach for the Quantitation of Drug Synergism to the Combination of cis-Diamminedichloroplatinum and 1-13-D-Arabinofuranosylcytosine", CANCER RESEARCFI, vol. 50, 1990, pages 5318 - 5327 | Type: | Non-patent literature | Publication information: | LIPINSKI: "Bioisosterism In Drug Design", ANNUAL REPORTS IN MEDICINAL CHEMISTRY, vol. 21, 1986, pages 283 | Type: | Non-patent literature | Publication information: | YUN: "Application Of Bioisosterism To New Drug Design", HWAHAK SEKYE, vol. 33, 1993, pages 576 - 579 | Type: | Non-patent literature | Publication information: | ZHAO, HUAXUE TONGBAO, BIOISOSTERIC REPLACEMENT AND DEVELOPMENT OF LEAD COMPOUNDS IN DRUG DESIGN, 1995, pages 34 - 38 | Type: | Non-patent literature | Publication information: | GRAHAM; THEOCHEM, THEORETICAL STUDIES APPLIED TO DRUG DESIGN:AB INITIO ELECTRONIC DISTRIBUTIONS IN BIOISOSTERES, vol. 343, 1995, pages 105 - 109 | Type: | Non-patent literature | Publication information: | T.W. GREEN; P.G.M.WUTS: "Protective Groups in Organic Chemistry", 1991, JOHN WILEY AND SONS | Type: | Non-patent literature | Publication information: | T.W. GREENE; P.G.M. WUTS: "Protective Groups in Organic Synthesis, 2nd edition,", 1991, JOHN WILEY & SONS | Type: | Non-patent literature | Publication information: | "Nomenclature of a-Amino Acids", BIOCHEMISTRY, vol. 14, no. 2, 1975 | Type: | Non-patent literature | Publication information: | T.W. GREEN; P.G.M. WUTS: "Protective Groups in Organic Chemistry", 1991, JOHN WILEY AND SONS | Type: | Non-patent literature | Publication information: | "Encyclopedia of Pharmaceutical Technology", vol. 10, pages: 33 | Type: | Non-patent literature | Publication information: | GUILLENA, G. ET AL., J. ORG. CHEM., vol. 65, 2000, pages 7310 - 7322 | Type: | Non-patent literature | Publication information: | "Design of Prodrugs", 1985, ELSEVIER | Type: | Non-patent literature | Publication information: | "Methods in Enzymology", vol. 42, 1985, ACADEMIC PRESS, pages: 309 - 396 | Type: | Non-patent literature | Publication information: | KROGSGAARD-LARSEN AND H. BANDAGED,: "A Textbook of Drug Design and Developement" | Type: | Non-patent literature | Publication information: | DESIGN AND APPLICATIONS OF PRODRUGS, 1991, pages 113 - 191 | Type: | Non-patent literature | Publication information: | H. BUNDGARD, ADVANCED DRUG DELIVERY REVIEWS, vol. 8, 1992, pages 1 - 38 | Type: | Non-patent literature | Publication information: | J. PHARM. SCI., vol. 77, 1988, pages 285 | Type: | Non-patent literature | Publication information: | N. NAKEYA ET AL., CHEM. PHARM. BULL., vol. 32, 1984, pages 692 | Type: | Non-patent literature | Publication information: | T. HIGUCHI; V. STELLA: "A.C.S. Symposium Series, and Bioreversible Carriers in Drug Design", vol. 14, 1987, AMERICAN PHARMACEUTICAL ASSOCIATION AND PERGAMON PRESS | Type: | Non-patent literature | Publication information: | S.M. BERGE ET AL.: "Pharmaceutical Salts", J. PHARM. SCI., vol. 66, 1977, pages 1 - 19 |